Paper7424945
Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.
Franciosa JA and 2 others. Am J Med, 1980. Cited by 175 papers, by iCite.
Cite this record
ConductScience Library. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Papers, record 7424945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7424945
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heart Failure | Major topic |
| Isosorbide Dinitrate | Major topic |
| Physical Exertion | Major topic |
| Aged | |
| Double-Blind Method | |
| Hemodynamics | |
| Humans | |
| Middle Aged | |
| Oxygen Consumption | |
| Placebos | |
| Pulmonary Wedge Pressure | |
| Random Allocation |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 5T32-HL07184 | NHLBI NIH HHS | United States | T32HL007184 | PubMed and NIH |
Source NIH RePORTER
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 175 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40806350 | Cardioprotective Role of Captopril: From Basic to Applied Investigations. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806350 | PubMed |
| 40608855 | Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure. | Circ Res | 2025 | https://conductscience.org/library/papers/40608855 | PubMed |
| 39101201 | Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial. | Circulation | 2024 | https://conductscience.org/library/papers/39101201 | PubMed |
| 37030529 | Reducing Pulmonary Capillary Wedge Pressure During Exercise Exacerbates Exertional Dyspnea in Patients With Heart Failure With Preserved Ejection Fraction: Implications for V˙/Q˙ Mismatch. | Chest | 2023 | https://conductscience.org/library/papers/37030529 | PubMed |
| 34640427 | Contemporary Pillars of Heart Failure with Reduced Ejection Fraction Medical Therapy. | J Clin Med | 2021 | https://conductscience.org/library/papers/34640427 | PubMed |
| 26549714 | Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26549714 | PubMed |
| 25605640 | Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design. | Circ Heart Fail | 2015 | https://conductscience.org/library/papers/25605640 | PubMed |
| 9288558 | Simultaneous evaluation of left- and right-sided heart pumping function during dynamic leg exercise in patients with mild chronic congestive heart failure, with special reference to afterload and plasma noradrenaline. | Heart Vessels | 1997 | https://conductscience.org/library/papers/9288558 | PubMed |
| 8129862 | Phosphodiesterase inhibitors. Do the risks outweight the benefits? | Drug Saf | 1993 | https://conductscience.org/library/papers/8129862 | PubMed |
| 8086321 | Treatment of infarct related heart failure: vasodilators other than ACE inhibitors. | Cardiovasc Drugs Ther | 1994 | https://conductscience.org/library/papers/8086321 | PubMed |
| 8037993 | Lack of effect of nitrates on exercise tolerance in patients with mild to moderate heart failure caused by coronary disease already treated with captopril. | Br Heart J | 1993 | https://conductscience.org/library/papers/8037993 | PubMed |
| 7946763 | Physiological rationale for co-treatment with diuretics in heart failure. | Br Heart J | 1994 | https://conductscience.org/library/papers/7946763 | PubMed |
| 7523062 | Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III. | Drugs | 1994 | https://conductscience.org/library/papers/7523062 | PubMed |
| 7488449 | Failure of "effective" treatment for heart failure to improve normal customary activity. | Br Heart J | 1995 | https://conductscience.org/library/papers/7488449 | PubMed |
| 6125370 | Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification. | Drugs | 1982 | https://conductscience.org/library/papers/6125370 | PubMed |
| 3899148 | Drug treatment of heart failure. | Br Heart J | 1985 | https://conductscience.org/library/papers/3899148 | PubMed |
| 3552590 | The role of vasodilator therapy in the treatment of severe chronic heart failure. | Drugs | 1986 | https://conductscience.org/library/papers/3552590 | PubMed |
| 3513808 | Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise. | Br Heart J | 1986 | https://conductscience.org/library/papers/3513808 | PubMed |
| 3044507 | Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects. | BMJ | 1988 | https://conductscience.org/library/papers/3044507 | PubMed |
| 3024949 | The treatment of heart failure. A methodological review of the literature. | Drugs | 1986 | https://conductscience.org/library/papers/3024949 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7424945
GET https://conductscience.org/api/papers/v1/7424945/cited_by?page=2